China Pharma Holdings (CPHI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 345 | 627 | 1,424 | 2,030 | 4,859 |
| Marketable Securities | N/A | 19 | 66 | 14 | 91 |
| Receivables | 291 | 262 | 662 | 451 | 744 |
| Inventories | 1,621 | 2,266 | 3,733 | 2,948 | 3,340 |
| Other current assets | 7 | 15 | 2 | 445 | 0 |
| TOTAL | $2,346 | $3,270 | $5,997 | $5,965 | $9,093 |
| Non-Current Assets | |||||
| PPE Net | 4,392 | 4,883 | 7,100 | 9,973 | 13,281 |
| Intangibles | 24,079 | 6,695 | 3,255 | 1,808 | 148 |
| Other Non-Current Assets | 182 | 38 | 117 | 39 | 128 |
| TOTAL | $28,653 | $11,617 | $10,472 | $11,820 | $13,556 |
| Total Assets | $31,000 | $14,888 | $16,469 | $17,784 | $22,650 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,977 | 1,016 | 1,031 | 2,441 | 4,329 |
| Accounts payable and accrued liabilities | 4,889 | 3,553 | 4,383 | 5,533 | 5,591 |
| Accrued Expenses | 351 | 247 | 299 | 405 | 299 |
| Other current liabilities | 112 | 162 | 91 | 520 | 210 |
| TOTAL | $7,400 | $5,017 | $6,821 | $12,740 | $10,513 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 1,391 | 1,412 | N/A | 5,250 |
| Other Non-Current Liabilities | 112 | 0 | 40 | 0 | 44 |
| TOTAL | $859 | $2,122 | $2,194 | $755 | $6,119 |
| Total Liabilities | $8,260 | $7,140 | $9,015 | $13,494 | $16,632 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 40,522 | 3,262 | 1,482 | 169 | 95 |
| Common Shares | 16 | 3 | 11 | 2 | 47 |
| Retained earnings | -47,214 | -44,027 | -39,290 | -36,212 | -32,239 |
| Other shareholders' equity | 11,403 | 11,140 | 11,452 | 11,573 | 12,564 |
| TOTAL | $22,740 | $7,748 | $7,455 | $4,290 | $6,018 |
| Total Liabilities And Equity | $31,000 | $14,888 | $16,469 | $17,784 | $22,650 |